Code
01G01524
Duration
01 January 2024 → 31 December 2027
Funding
Regional and community funding: Special Research Fund
Promotor-spokesperson
Research disciplines
-
Natural sciences
- Intracellular compartments and transport
-
Medical and health sciences
- Adaptive immunology
- Innate immunity
- Biopharmaceuticals
- Vaccines
Keywords
mRNA vaccines
dendritic cells
immune response
Project description
This project aims to put UGent at the forefront of mRNA-vaccine research by providing in-depth insights in the adjuvant properties of LNP-based mRNA-vaccines. To this end, we will join the expertise of 3 teams working on dendritic cell biology, nucleic acid sensors and lipid nanoparticles respectively.This consortium will form the basis for the development of vaccines against autoimmune diseases.